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1D LC ESI MS/MSMarek's disease virus (MDV), which causes a lymphoproliferative disease in chickens, is known to
induce host responses leading to protection against disease in a manner dependent on genetic
background of chickens and virulence of the virus. In the present study, changes in the spleen proteome
at 7, 14 and 21 days post-infection in response to MDV infection were studied using two-dimensional
polyacrylamide gel electrophoresis. Differentially expressed proteins were identiﬁed using one-
dimensional liquid chromatography electrospray ionization tandem mass spectrometry (1D LC ESI
MS/MS). Comparative analysis of multiple gels revealed that the majority of changes had occurred at
early stages of the disease. In total, 61 protein spots representing 48 host proteins were detected as
either quantitatively (false discovery rate (FDR)≤0.05 and fold change≥2) or qualitatively differentially
expressed at least once during different sampling points. Overall, the proteins identiﬁed in the present
study are involved in a variety of cellular processes such as the antigen processing and presentation,
ubiquitin–proteasome protein degradation (UPP), formation of the cytoskeleton, cellular metabolism,
signal transduction and regulation of translation. Notably, early stages of the disease were characterized
by changes in the UPP, and antigen presentation. Furthermore, changes indicative of active cell
proliferation as well as apoptosis together with signiﬁcant changes in cytoskeletal components that
were observed throughout the experimental period suggested the complexity of the pathogenesis. The
present ﬁndings provide a basis for further studies aimed at elucidation of the role of these proteins in
MDV interactions with its host.© 2009 Elsevier Inc. All rights reserved.IntroductionMarek's disease (MD) in chickens is caused by Gallid herpesvirus 2
(GaHV-2) or Marek's disease virus (MDV). Hereafter, this virus is
referred to asMDV.MDV is a highly prevalent alpha-herpesvirus and the
disease it causes is characterized by transient neurological signs and
immunosuppression at early stages that could subsequently be followed
by lymphoma formation in various visceral organs in susceptible birds.
Upon infection via inhalation, in all infected birds, MDV is taken to
various lymphoid organs, such as spleen, thymus and bursa of Fabricius
where early cytolytic infection in B cells that proceeds to latent infection
of T cells occurs. While a lifelong latent phase could occur in genetically
MD-resistant birds and in those protected by vaccination, late reactiva-
tion of latent virus in susceptible birds could cause transformation of
mainly CD4+Tcells, leading to lymphoma formation.Meanwhile, active
replication of MDV occurs in feather follicles of infected birds regardless
of their genetic susceptibility rendering them a continuous source of
infectious viruses (Baigent and Davison, 2004). Although MD isncipal investigators.
ll rights reserved.currently controlled by vaccination, there have been periodical MD
outbreaks caused by new strains of MDV with increased virulence
(Witter, 1997). The potential of MDV to evolve and overcome vaccinal
immunity is considered as a major threat for a sustainable MD control
strategy.However,manyaspects ofMDV–host interactionsare still being
elucidated (Baaten et al., 2004).
To date, several studies have been conducted to examine host gene
expression in response to MDV infection on a relatively large scale
using various genomic techniques, such as microarrays. Changes in
gene expression of chicken embryo ﬁbroblasts (CEF) infected with
RB1B, a very virulent strain of MDV, were studied by Morgan et al.
(2001) using a microarray containing 1126 expressed sequence tags.
These authors reported the differential expression of a number of host
genes including those associated with inﬂammation, antigen pre-
sentation and cell growth. An in vivo study byour groupusing the same
virus strain and a small-scale microarray has revealed signiﬁcant
changes in the expression of genes encoding cell surface molecules,
transcription and signal transduction molecules as well as cytokines
(Sarson et al., 2006). While studies of this nature, in the context of MD
inparticular and various other viruses in general (reviewed in Piersanti
et al., 2004) would certainly enhance our understanding of host–
pathogen interactions, further expansion of this knowledge with
357N. Thanthrige-Don et al. / Virology 390 (2009) 356–367proteomic studies is still important (reviewed in Burgess, 2004; Zhang
et al., 2005). This is partly because of the possible inconsistency
between the expression of genes at the transcript and protein levelsFig.1. Representative 2D gel images of MDV-infected and uninfected control spleen proteome
successfully identiﬁed protein spots that were uniquely expressed (qualitative differences
corresponding spot numbers and to Fig. 2 for the map of quantitatively differentially expre(Gygi et al., 1999). Furthermore, viruses can induce post-translational
modiﬁcations in host proteins without affecting the mRNA expression
(Liu et al., 2001).s with their respective sampling points. Arrows with accompanying spot numbers show
) in each group at corresponding time point. Please refer to Table 1 for identities of
ssed spots.
Fig. 2. A representative gel image showing 2D gel electrophoresis map of the relative locations of spots that displayed signiﬁcant quantitative differential expression (FDR≤0.05 and
fold change≥2) at least once during different sampling times. This image represents the proteome of 7 dpi MDV-infected spleen. Because of the absence of certain spots in this gel,
arrows for spot 111, 968, 1576 and 1609 represent the relative positions only. Please refer to Table 1 for identities of corresponding spot numbers and to Fig. 1 for maps of qualitatively
differentially expressed spots.
358 N. Thanthrige-Don et al. / Virology 390 (2009) 356–367In a recent in vitro proteomic study, Ramaroson et al. (2008)
inventoried 1460 and 1676 proteins expressed in MDV-infected and
mock-infected CEF, respectively. Several other proteomic studies in the
context of MD have been conducted to model the proteome of MDV-
transformed CD4+ T lymphocytes in vitro. Notably, proteomicFig. 3. Comparison of total numbers of signiﬁcantly differentially expressed protein
spots in MDV-infected spleens at various sampling time points. In calculation of total
number of spots in each category, newly induced protein spots were considered as up-
regulation and the absence of spots compared to uninfected controls was considered as
down-regulation.modeling of MDV-transformed CD30hi CD4+ T lymphocytes has
suggested that these cells exhibit a regulatory T cell phenotype (Buza
and Burgess, 2007; Shack et al., 2008). Further, such studies have been
able to describe the fundamental differences between MDV-trans-
formed T cells and their non-transformed healthy counterparts with
regard to activated signalling pathways (Buza and Burgess, 2008).
With respect to viral protein expression, Liu et al. (2006) identiﬁed a
number of unique proteins expressed during the lytic phase of MDV-
infected CEF using a mass spectrometry-based proteomic approach.
These studies highlight the potential of various proteomic tools in
understanding the dynamics of host–pathogen interactions during
various phases of MD.
The current study was intended to investigate the dynamics of host
protein expression across the various phases of MDV life cycle in MDV-
infected chickens.Whilewewere able to detectmore than500 separate
protein spots for each sample, herewe reportmore than60 signiﬁcantly
differentially expressed proteins identiﬁed using two-dimensional gel
electrophoresis (2DE) and mass spectrometry. Putative importance of
some of these proteins in the context of MD is discussed.
Results
Spot proﬁles of 2D PAGE of MDV-infected and uninfected control
chicken spleens
Proteins from spleens of MDV-infected and uninfected control
chickens at 7, 14 and 21 days post-infection (dpi) were extracted and
analyzed by 2DE in order to compare the protein expression proﬁles
between each group. On average, 517±84 distinct protein spots
could be resolved by 2DE using pH 3-10NL IPG strips loaded with
Table 1
List of differentially expressed protein spots in MDV-infected spleen tissues identiﬁed by 1D LC ESI MS/MS.
Ref.
spot no.
Protein namea Fold change
in expression
Number
of
peptides
identiﬁed
Protein
coverageb
(%)
Probability Protein
scorec
Accession
no.
Mr. (predicted/
observed) (kDa)
7 dpi 14 dpi 21 dpi
Cellular structural proteins
1738 PREDICTED: similar to Coactosin-like
1 (Dictyostelium) (COTL1)
IN 1.6 REP 1 17 5.3E−12 5.62 gi|118096533 15.9/15.34
628 Beta-actin (ACTB) 4.2 1 1.1 3 12 5.0E−40 28.36 gi|45382927 41.7/34.23
1614 Beta-actin (ACTB) IN IN AB 1 3 0.00028 2.95 gi|45382927 41.7/37.84
1616 Beta-actin (ACTB) IN 4.9 IN 4 28 7.8E−69 38.18 gi|45382927 41.7/36.15
1757 Beta-actin (ACTB) IN IN AB 2 9 1.2E−28 16.17 gi|45382927 41.7/34.20
1567 Beta-actin (ACTB) 2.5 2 1.8 4 19 6.2E−55 41.75 gi|45382927 41.7/36.54
1615 Actin, alpha 2, smooth
muscle, aorta (ACTA2)
IN AB REP 2 8 1.4E−12 5.93 gi|71895043 42.0/36.90
762 Actin, alpha 2, smooth
muscle, aorta (ACTA2)
4.2 1.8 1.3 4 11 1.8E−38 26.37 gi|71895043 42.0/28.52
709 Actin, alpha 2, smooth
muscle, aorta (ACTA2)
2.7 2.5 1 3 8 1.1E−32 20.67 gi|71895043 42.0/30.65
325 Tubulin, beta 2B (TUBB2B) −3.3 −1.1 1.6 12 63 2.0E−139 106.89 gi|52138699 49.9/56.70
1755 Lamin B2 (LMNB2) IN IN IN 8 24 4.3E−54 45.33 gi|45384202 67.9/40.33
1426 Lamin B2 (LMNB2) 3.1 IN 1.3 7 19 4.7E−60 48.54 gi|45384202 67.9/40.65
Protein translation and elongation
1763 Eukaryotic translation
elongation factor 2 (EEF2)
IN IN 1.9 9 23 9.9E−81 46.07 gi|45382453 95.4/33.69
612 Eukaryotic translation
elongation factor 2 (EEF2)
3.2 1.1 1.5 8 19 4.3E−93 57.94 gi|45382453 95.4/34.01
1782 Acidic ribosomal
phosphoprotein (RPLP0)
REP 1 AB 6 31 7.6E−56 39.02 gi|45384494 34.3/36.14
RNA processing
1626 Heterogeneous nuclear
ribonucleoprotein A2/B1 (HNRNPA2B1)
IN IN AB 1 4 5.9E−10 7.72 gi|71896753 36.8/23.05
1631 PREDICTED: heterogeneous nuclear
ribonucleoprotein A3 (HNRNPA3)
3.6 2.3 −1.8 3 17 1.1E−19 9.52 gi|118093536 39.6/29.05
541 Heterogeneous nuclear
ribonucleoprotein H3 (2H9) (HNRNPH3)
−3.7 −1.4 1.3 7 38 8.9E−69 45.22 gi|60302824 36.5/36.50
Ubiquitin–proteasome pathway, antigen processing and presentation and proteolysis
769 Ubiquitin carboxyl-terminal esterase
L3 (UCHL3)
−2.5 −1.5 −1.4 2 14 4.9E−17 14.20 gi|45382251 26.3/28.34
710 Proteasome (prosome, macropain)
subunit, beta type, 7 (PSMB7)
REP −1.3 1.1 2 13 2.1E−15 12.47 gi|45383366 29.9/30.78
1576 PREDICTED: similar to mSUG1
protein (PSMC5)
REP AB 2.6 2 19 3.3E−24 13.53 gi|118102836 45.6/47.87
1171 Cathepsin D (CathD) 2.8 2 2.5 2 13 1.0E−14 8.96 gi|45384002 43.3/13.30
1747 Cathepsin D (CathD) 2 2.5 1.8 1 7 2.8E−10 6.57 gi|45384002 43.3/28.46
494 Cathepsin D (CathD) REP −1.2 −1.9 1 7 1.8E−10 5.32 gi|45384002 43.3/39.21
1569 MHC class II alpha chain (B-LA) −3.6 1 −1.3 1 14 0.00099 3.33 gi|118099043 28.0/32.14
Signal transduction
1609 PREDICTED: similar to
D4-GDP-dissociation inhibitor (D4-GDI)
5.3 1.6 −1.3 1 4 0.00745 2.26 gi|50728568 23.0/18.40
775 PREDICTED: similar to
D4-GDP-dissociation inhibitor (D4-GDI)
−2.7 −2.5 −1.6 5 49 2.3E−77 51.21 gi|50728568 23.0/27.15
1174 Membrane associated guanylate
kinase, WW and PDZ domain containing
(MAGI3)
6.3 2.7 3.4 1 3 0.00043 2.40 gi|60593020 12.2/13.70
583 Guanine nucleotide binding protein
(G protein), beta polypeptide 1 (GNB1)
−2 −1.2 −1.2 1 8 6.3E−21 9.42 gi|61098210 37.3/35.15
Transport
1125 Transthyretin (TTR) REP −1.1 REP 1 11 4.0E−05 2.96 gi|45384444 16.3/15.28
1607 Alpha 2 globin (HBA2) 2.8 1 −1.3 9 85 1.9E−95 76.78 gi|52138645 15.7/27.34
1155 Fatty acid binding protein 4,
adipocyte (FABP4)
REP AB AB 5 56 4.7E−46 29.37 gi|45383556 14.8/14.55
1143 Fatty acid binding protein 3 (FABP3) 1.2 IN IN 3 80 4.2E−87 50.64 gi|71894843 14.8/14.80
1605 PREDICTED: similar to voltage-gated
sodium channel type II alpha subunit
(SCN2A)
IN AB AB 1 2 0.00661 3.15 gi|118093616 25.5/32.35
Cell proliferation, differentiation and DNA repair
598 Proliferating cell nuclear antigen (PCNA) −1.6 1.4 2.7 6 46 3.1E−45 29.16 gi|45383776 28.9/34.36
1781 Nucleophosmin 1 (NPM1) 3.2 1.1 1.5 1 6 1.1E−14 8.85 gi|45383996 32.6/20.09
1040 Stathmin 1/oncoprotein 18 (STMN1) REP 1 IN 1 13 1.0E−09 5.36 gi|50053682 17.1/18.67
(continued on next page)
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Table 1 (continued)
Ref.
spot no.
Protein namea Fold change
in expression
Number
of
peptides
identiﬁed
Protein
coverageb
(%)
Probability Protein
scorec
Accession
no.
Mr. (predicted/
observed) (kDa)
7 dpi 14 dpi 21 dpi
Enzymes
1769 Triosephosphate isomerase 1 (TPI1) IN AB AB 2 13 5.0E−08 5.76 gi|45382061 26.6/27.19
789 Triosephosphate isomerase 1 (TPI1) −2.3 −1.5 −1.4 3 18 4.5E−25 22.54 gi|45382061 26.6/27.26
1604 PREDICTED: aldolase B,
fructose-bisphosphate (ALDOB)
5.2 2.7 2.6 1 2 1.9E−05 4.90 gi|50761947 39.3/38.76
1629 PREDICTED: aldolase B,
fructose-bisphosphate (ALDOB)
−5.4 −1.6 1 1 2 0.00261 2.48 gi|50761947 39.3/39.68
791 Glutathione-S-transferase theta 1
(GSTT1)
−1.4 REP 1 1 13 0.00015 2.41 gi|45382479 29.8/27.14
1596 Phosphoglycerate mutase 1 (brain)
(PGAM1)
−4.9 1 IN 10 83 4.1E−169 95.00 gi|71895985 28.9/29.17
283 Amylase, alpha 2A; pancreatic
(AMY2A)
−3.5 −1.3 −5.7 13 72 3.9E−180 120.50 gi|47825395 57.5/58.61
Protein folding/stress response
1702 Heat shock cognate 70 (HSC70) IN AB AB 9 31 2.3E−141 87.04 gi|45384370 70.8/66.08
1603 Heat shock protein 70 (HSP70) IN AB REP 2 6 1.5E−27 16.43 gi|55742654 69.7/40.14
1735 Heat shock protein 70 (HSP70) IN REP REP 3 10 6.7E−25 18.12 gi|55742654 69.7/69.27
Antioxidant
1527 PREDICTED: similar to natural killer
cell enhancing factor isoform 4 (NKEF)
6.3 2 1.2 7 49 5.1E−78 60.88 gi|50751518 22.1/24.61
1606 PREDICTED: similar to natural killer
cell enhancing factor isoform 4 (NKEF)
IN IN IN 6 48 4.6E−113 86.61 gi|50751518 22.1/23.77
Other
1753 Cadherin 4, type 1, R-cadherin
(retinal) (CADH4)
IN AB AB 1 5 0.000240 2.68 gi|52138677 100.8/26.5
1427 Serine (or cysteine) proteinase inhibitor,
clade B (ovalbumin), member 6
(SERPINB6)
REP −1.4 −2.7 4 19 5.2E−33 19.89 gi|57530448 42.9/40.60
917 Ferritin, heavy polypeptide 1 (FTH1) AB 1.2 REP 3 30 3.8E−38 19.77 gi|45384172 21.1/21.64
1612 Myosin regulatory light chain 9 (MYL9) IN 1.9 1.3 1 7 5.6E−08 5.76 gi|45384118 19.8/21.52
968 Myosin regulatory light chain,
isoform L20-B (MYLL20B)
−2.3 1 REP 2 15 2.7E−12 8.38 gi|45384410 19.8/20.42
704 Transglutaminase 4 (prostate) (TGM4) 8 −1.3 −1.1 7 15 3.8E−84 56.85 gi|57530757 78.8/30.85
111 Transglutaminase 4 (prostate) (TGM4) −2.7 −2.5 −1.6 9 24 8.2E−121 65.80 gi|57530757 78.8/89.70
Hypothetical proteins
1765 PREDICTED: hypothetical protein (HP1) IN AB AB 2 19 5.0E−17 8.34 gi|50731161 34.5/35.40
585 PREDICTED: hypothetical protein (HP2) −2.3 1 −1.2 3 15 6.3E−29 19.97 gi|50745642 34.8/34.74
1655 PREDICTED: hypothetical protein (HP3) REP REP REP 1 5 9.7E−05 1.12 gi|50761148 38.4/22.29
347 PREDICTED: hypothetical protein,
partial (HP4)
IN 1 1.8 8 16 3.8E−54 44.03 gi|118093732 51.7/55.78
1610 PREDICTED: hypothetical protein (HP5) 2.2 2.8 3.7 1 3 1.2E−07 6.58 gi|118086389 32.8/20.78
IN = induced, detected only in infected group, REP = repressed, detected only in the control group, AB = absent in both groups, dpi = days post-infection.
a Protein abbreviations are in parentheses.
b Protein coverage=(total amino acids in detected peptides/total amino acids in peptides detectable bymass spectrometer)×100 (seeMaterials andmethods section for details).
c Protein score is the sum of Xcorr values obtained from Bioworks analysis.
360 N. Thanthrige-Don et al. / Virology 390 (2009) 356–367200 μg of total proteins. The molecular weights of spots ranged from
8 to 120 kDa. Differences in spot intensity were identiﬁed as either
qualitative or quantitative changes (Figs. 1 and 2). On average there
were over 500 spots on each gel, however only 309, 375 and 341
spots from each group at consecutive sampling points were
considered for statistical comparison. Because, according to our
selection criteria, only those spots which were present in at least 3 of
4 gels in both infected and control groups at a given sampling point
were considered for quantitative comparisons. The highest number
of qualitative differences in spots was detected at 7 dpi (n=26). This
number decreased in the subsequent sampling time point at 14 dpi
(n=19) and the lowest number was at 21 dpi (n=7). Although a
similar pattern was seen in the total number of spot differences, the
highest number of quantitatively signiﬁcant differences (false
discovery rate or FDR≤0.05 and fold change≥2) in spot expression
was detected at 7 dpi (n=33), which was followed by 21 dpi
(n=12) and 14 dpi (n=2). Among these spots, there were 16, 1 and
5 spots identiﬁed as signiﬁcantly up-regulated at 7, 14 and 21 dpi,
respectively. The rest were signiﬁcantly down-regulated (Fig. 3).Taken together, 61 protein spots were detected as either quantita-
tively or qualitatively differentially expressed at least once during
different sampling points.
Identiﬁcation of differentially expressed proteins by mass spectrometry
In order to obtain the identities of the differentially expressed spots,
the spots were manually excised from preparative gels prepared by
loading 1 mg of total proteins and staining with Coomassie blue.
Subsequently, trypsin-digested spots were identiﬁed by 1D LC ESI MS/
MS. Peptide identities with FDRb0.01 were considered signiﬁcant and,
in total, the identity of proteins in 61 different spots representing 48
different proteins was determined (Table 1). Moreover, several spots
contained peptides generated from multiple proteins. While we have
used the proteinwith the highest relative abundanceunder correspond-
ing spot number throughout our discussion, the complete list of spots
with multiple identities has been provided as supplementary Table 1.
Several proteins were differentially expressed at more than one
time point, e.g. cathepsin D (CathD), natural killer cell enhancing
Fig. 4. Venn diagram summarizing the spots that were signiﬁcantly differentially expressed in the spleen tissues of MDV-infected chickens according to their corresponding time of
sampling. These identities include both quantitatively and qualitatively differentially expressed spots. The identities of spots which were commonly expressed were placed in
overlapping areas accordingly. Corresponding spot numbers are in parentheses. Refer to Table 1 for the respective protein names.
361N. Thanthrige-Don et al. / Virology 390 (2009) 356–367factor isoform 4 (NKEF), eukaryotic elongation factor 2 (EEF2),
aldolase B (ALDOB), membrane associated guanylate kinase
(MAGI3), a predicted hypothetical protein (HP5) and beta actin
(ACTB) at all three times. In total, 30 proteins were differentiallyFig. 5. Gene Ontology analysis of signiﬁcantly changed proteins according to their biological p
at Agbase database (http://www.agbase.msstate.edu/) as described in the Materials and mexpressed exclusively at 7 dpi. Notably, several proteins involved in
antigen presentation pathways, the ubiquitin–proteasome protein
degradation system and a number of spots representing several
cellular structural proteins were among those that were differentiallyrocess. This classiﬁcationwas produced based on the analysis using GOSlimViewer tool
ethods section.
Fig. 6. MDV genome load in infected spleens. Chickens were infected with the RB1B
strain of MDV and sampled at 7, 14 and 21 days post-infection. Meq copy numbers in
100 ng of spleen DNA were quantitated using real-time PCR. At least three spleen
samples were analyzed in duplicate at each sampling time point. The error bars
represent standard error of the mean.
362 N. Thanthrige-Don et al. / Virology 390 (2009) 356–367expressed exclusively at 7 dpi. Therewas only one spot speciﬁc to each
of 14 and 21 dpi. These spots were identiﬁed as glutathione-S-
transferase theta 1 (14 dpi) and proliferating cell nuclear antigen
(21 dpi). The signiﬁcant changes detected with the rest of the spots
overlapped between each time point in varying numbers.
Interestingly, some of the spots representing a particular protein
showed opposite directions of regulation evenwithin the same group.
For example, three spots with different molecular weights and pIwere
identiﬁed as CathD (Table 1). Of these three spots, two spots with
molecular weights of 13.3 and 28.4 kDawere found to be up-regulated
in infected birds at more than one time point. The summarized
distribution of the identities of spots identiﬁed at each time point is
presented in Fig. 4.
Gene Ontology annotation
Forty-percent of the identiﬁed proteins were associated with the
cytoplasm and the plasma membrane (terms GO:0005737 and
GO:0005886 respectively). Furthermore, there were 24% nuclear
and nuclear envelope proteins (GO:0005634 and GO:0005635), 22%
cytoskeleton-associated proteins (GO:0005856) and 5% extracellular
proteins (GO:0005576). Nine-percent of proteins did not have any
GO annotation with respect to their cellular compartment, hence,
were categorized very broadly as being associated as a “cellular
component” (GO:0005575). For biological processes, the highest
associations (18%) were with metabolic processes (GO:0008152).
Another 16% associations were with nucleic acid metabolism
(GO:0006139), while 14% and 13% were associations with transport
(GO:0006810) and cell communication (GO:0007154), respectively.
Among the remaining associations, 4% were associated with cell
death (GO:0008219) (Fig. 5).
Determination of MDV genome load in infected spleens
Virus genome copy numbers in infected spleens were determined
using quantitative real-time PCR (qPCR). Using conventional PCR
screening, MDV-Meq gene could be ampliﬁed from DNA of all infected
spleens but not from any of the uninfected controls (data not shown).
Results of the subsequent qPCR analysis of infected samples are
presented in Fig. 6. The average MDV-Meq copy numbers were
3.82×106±1.48×106 (n=3), 2.66×107±7.78×106 (n=3) and
2.98×107±1.22×107(n=4) per 100 ng of spleen DNA at 7, 14 and
21 dpi, respectively (Fig. 6). There was a statistically signiﬁcant
difference between genome copy numbers at 7 dpi compared to other
time points.Discussion
In the present study, we have proﬁled the global protein
expression changes in the chicken spleen in response to MDV
infection at various time points representing the different phases of
MDV life cycle. Furthermore, we have determined the identity of the
spots that were differentially expressed between infected and
uninfected birds using mass spectrometry.
Among the 48 proteins that were differentially expressed, there
was considerable number of proteins that had multiple spots in 2D
gels. In addition, there was some degree of disagreement between the
expected and experimental molecular weights in case of some of the
proteins. This could be due to several reasons. First, some proteins
exist as different isoforms (therefore different pI) as well as different
intermediate stages between translation and functionally mature
form (i.e. pre-pro- and pro-forms of protein). This could change the
molecular weight and/or the isoelectric point (for example, please see
the discussion regarding different spots of CathD below). Another
reason is possible protein degradation between sample collection and
processing. Interestingly, no protein with multiple matches showed
any speciﬁc migration pattern in our 2D gels (such as trains of spots).
While current data are not enough to determine the exact reason for
such discrepancies, it should be noted that several previous studies
using 2D gels have also reported the presence of similar patterns of
proteins with multiple spots (Dupont et al., 2008; Liu et al., 2008;
Saldanha et al., 2008; Zheng et al., 2008).
Analysis of viral load in spleen tissue revealed a signiﬁcant increase
over time. Although viral genome load may not be a direct indicator
for the degree of infection, there is a correlation between MDV
genome load and the number of infected cells (Bumstead et al., 1997)
as well as with subsequent MD incidence (Islam et al., 2006) or
protection conferred by vaccines against MD (Abdul-Careem et al.,
2007). Based on our previous observations, virus genome load of
around 1×105 copies/100 ng of spleen DNA is correlated with
development of tumors in infected birds (Abdul-Careem et al., 2007).
Therefore, it is conceivable that the virus copy numbers observed in
the present study would be an indicative of a high level of infection.
The proteins identiﬁed in the present study are involved in a
variety of cellular processes, notably the antigen processing and
presentation, ubiquitin–proteasome protein degradation, formation of
the cytoskeleton, cellular metabolism, signal transduction and
regulation of translation (Table 1). The signiﬁcance of these processes
in chicken-MDV interaction is discussed below. Although this was not
determined in the present study, temporal changes in the cellular
composition of the spleen may have, at least in part, inﬂuenced the
whole spleen organ proteome. However, the advantage of our method
is that the proteins that are differentially expressed could be used to
point to cell subsets and/or mechanisms that have a potential
involvement in MDV–host interactions and could be targeted for
future studies.
Effects of MDV infection on the ubiquitin–proteasome pathway and
MHC antigen presentation
Among the differentially expressed spots, several proteins were
identiﬁed that are either directly or indirectly involved in the
ubiquitin–proteasome (UPP) and antigen presentation pathways
(Table 1). In our study, we identiﬁed three differentially regulated
proteins, namely ubiquitin C-terminal hydrolase L3 (UCHL3), protea-
some (prosome, macropain) subunit beta type 7 (PSMB7) and
predicted protein similar to mouse proteasome 26S subunit ATPase
5 (PSMC5) (also known as mSUG1), which are involved in UPP (Table
1). Among them, chicken UCHL3 (alias UCH-6) has 86% amino acid
similarity with its human counterpart (Baek et al., 1999), which is a
deubiqutinating enzyme (DUB) that functions as a negative regulator
of ubiquitination of proteins as well as facilitates recycling of
363N. Thanthrige-Don et al. / Virology 390 (2009) 356–367ubiquitin. Increasing evidence suggests that DUBs are important
regulators of many cellular processes such as endocytosis, apoptosis
and various signalling pathways (Wing, 2003). Several virus-encoded
proteins such as Epstein–Barr virus (EBV)-encoded Epstein–Barr
nuclear antigen 1 and herpes simplex virus (HSV-1) regulatory
protein ICP0 have been shown to interact with DUBs for viral survival
in infected cells (reviewed in Lindner, 2007). Although there is a high
amino acid identity between human UCH-L3 and chicken UCH-6, they
differ with respect to their substrate speciﬁcity and tissue distribution
(Baek et al., 1999). Therefore, the chicken ortholog of UCH-L3 may not
have a similar role in viral infections. More functional studies are
needed to understand the signiﬁcance of the down-regulation of
UCHL3 in MDV infection.
Down-regulation of PSMB7 at 7 dpi probably indicates the
modiﬁcation of proteasome into immunoproteasome under the
inﬂuence of interferon (IFN)-γ to enhance the generation of peptides
for binding to major histocompatibility complex (MHC) class I
molecules. In this process, three constitutive beta subunits of the
20S proteasome, namely delta, X and Z (PSMB7), are replaced by IFN-γ
inducible low molecular mass peptide (LMP)-7, LMP-2 and multi-
catalytic endopeptidase complex-like (MECL) catalytic subunits,
respectively (Grifﬁn et al., 1998). Although we could not detect up-
regulation of IFN-γ inducible subunits, given the reciprocal regulation
between constitutive and IFN-γ inducible subunits (Hisamatsu et al.,
1996), down-regulation of PSMB7 may indicate the effect of induced
IFN-γ. In line with that, MDV is known to induce IFN-γ in chickens as
early as 3 dpi and remains up-regulated until at least 15 dpi (Xing and
Schat, 2000). Moreover, although MDV is capable of down-regulating
MHC-I expression in vitro, elevated IFN-γ has been shown to reverse
the effect of MDV on MHC-I (Levy et al., 2003). Our present
observations do not provide evidence for differential regulation of
MHC-I expression. However, given the possible enhancement of
immunoproteasome activity, it is conceivable that there is an
enhanced MHC-I-mediated antigen presentation.
The 19S proteasome subunit SUG1 up-regulates MHC-II expression
by interaction with class II transactivator (CIITA) gene and MHC-II
proximal promoter in human. MHC-II expression is reduced in the
absence of the expression of SUG1 (Bhat et al., 2008). In agreementwith
this, the observed absence of predicted protein,mSUG1 in infected birds
is associated with a signiﬁcant decrease in the expression of the MHC
class II alpha chain (B-LA) in infected spleens at 7 dpi. Reduction of the
MHC-II expression is known to be a predominant way of evading the
host immune response by a number of viruses including herpesviruses
(Hegde et al., 2003). In agreement with our present observation of
down-regulation of MHC-II expression, previous work from our
laboratory showed that MDV infection causes signiﬁcant down-
regulation of invariant (Ii) chain gene expression in the chicken spleen
tissue (Sarson et al., 2006). In contrast to this observation, Niikura et al.
(2007) have shownanup-regulation ofMHC-II in bursa cells of chickens
infected with Md11, another very virulent strain of MDV. However, in
contrast to our present infection model which used outbred SPF
chickens, they have used chickens from a cross between two inbred
lines, 15I5 and 71, both of which are susceptible to MD (Bacon et al.,
2000). Therefore, it is possible that the difference in genetic background
of infected birds may have, at least in part, contributed to these
contradicting observations.
Taken together, our observations suggest that there is enhanced
antigen processing, presumably mediated by elevated IFN-γ for MHC
class I pathway, while there is a down-regulation of MHC class II-
mediated antigen presentation at least in our experimental model at
early stages of the disease.
Alterations in the proteins associated with the cytoskeleton network
In the current study, altered spot proﬁles were observed for a
number of cytoskeleton-associated proteins representing all threemain categories of cytoskeleton proteins, namely microﬁlaments,
intermediate ﬁlaments and microtubules. Among the microﬁlament
proteins, all detected actin spots, except for alpha-2 actin (ACTA2) and
a predicted protein similar to coactosin-like 1 (COTL1) at 21 dpi, were
either newly induced or signiﬁcantly up-regulated across the experi-
mental period. Intermediate ﬁlament, lamin B2 (LMNB2) spots also
were either up-regulated or newly induced in infected birds at all
times. However, microtubule protein, tubulin β 2B (TUBB2B) was
signiﬁcantly down-regulated in infected birds at 7 dpi (Table 1).
Changes in cytoskeleton proteins have been previously described
in several other viral infections, such as IBDV (Zheng et al., 2008),
severe acute respiratory syndrome (SARS)-associated coronavirus
(Jiang et al., 2005) and human papillomavirus type 8 (Akgül et al.,
2009). Herpesviruses are known to interact with the actin ﬁlament
system and its regulatory protein, Rho GTPase, at various stages of
infection (Favoreel et al., 2007). In addition to actins, here we have
identiﬁed a Rho GTPase regulatory protein, D4-GDI, as a protein that
was differentially expressed in spleen of infected chickens (discussed
in detail elsewhere in the Discussion). This may indicate a putative
role of the same system in the context of MDV infection. Schumacher
et al. (2005) showed that MDV-encoded US3 ortholog protein causes
depolymerization of the actin stress ﬁbers. However, its role in MDV
replication and/or spreading is still unclear. Stathmin 1 (STMN1),
which also plays a role in the regulation of the microtubule system,
has been shown to be up-regulated in EBV-infected B lymphocytes in
human as early as 7 dpi (Baik et al., 2007). In the present study, we
could not detect changes in STMN1 in spleen at 7 dpi. However, the
expression of this proteinwas induced by 21 dpi. As a possible result of
regulation by STMN1, TUBB2B, which is a component of the
microtubule ﬁlament system, also showed a similar pattern of
expression in MDV-infected spleen tissues. However, if that change
has any direct relationship with the STMN1 is not known. Apart from
its interaction with the microtubule system, STMN1 has been shown
to interact with heat shock protein 70 (HSP70) proteins, particularly
with heat shock cognate 70 (HSC70) (Manceau et al., 1999). In line
with that, we have also identiﬁed signiﬁcant changes in the
expression of HSP70 proteins, including HSC70.
Another cellular structural protein, LMNB2, which is associated
with the nuclear membrane, was up-regulated in infected birds
throughout the experimental period as a probable result of the egress
process of virus nucleocapsids from the infected nuclei. The
nucleocapsids of herpesviruses acquire a temporary envelope from
the inner nuclear membrane before egress by budding off from the
infected cell nuclei (Granzow et al., 2001). In line with that, Camozzi
et al. (2008) have reported various biochemical and structural
modulations, including mislocalization of lamin proteins in the
nuclear envelope of cells infected with human cytomegalovirus.
Although Camozzi et al. (2008) did not observe any quantitative
changes in the expression of lamin proteins, qualitative changes in the
expression of the same protein have been described in infections with
several other viruses such as IBDV (Zheng et al., 2008), enterovirus 71
(Leong and Chow, 2006) and SARS-associated coronavirus (Jiang et al.,
2005). Similar to the other members of the family, MDV particles
egress from the nucleus of infected cells through budding (Baigent
and Davison, 2004). Therefore, it is conceivable that the up-regulation
of LMNB2 protein observed in the present experiment is, at least
partly, the result of such interaction.
Mixed cell populations undergoing activation/proliferation as well as
apoptosis
Proliferating cell nuclear antigen (PCNA), which is one of the
critical proteins in cell survival, was signiﬁcantly up-regulated in
infected spleens at 21 dpi. PCNA is an essential component in DNA
synthesis process in the cell. Therefore, it is likely that induction of
PCNA represents highly replicating cell populations in the spleen at
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transformed cell population, possible interactions between PCNA and
viral proteins might be also occurring. For example, HSV-1 encoded
protein, ICP34.5, interacts with PCNA of infected cells, presumably
preventing virus-induced translational arrest (Brown et al., 1997;
Harland et al., 2003). The possibility of a yet unidentiﬁed MDV protein
interacting with PCNA remains to be investigated.
ICP34.5 has also been shown to interact with phosphatase 1,
preventing the inactivation of eukaryotic elongation factors (EEF), a
group of proteins which play an important role in protein biosynth-
eses, hence being important in various cell processes including
proliferation (Thompson and Sarnow, 2000). EEF2 was among the
proteins that were up-regulated at both 7 and 14 dpi. Increased levels
of EEF2 have been shown in response to human immunodeﬁciency
virus (HIV) protein, Vpr, and have been shown to have the potential of
preventing Vpr-mediated apoptosis in CD4+ T cells (Zelivianski et al.,
2006). D4-GDP-dissociation inhibitor (D4-GDI) (also known as Ly-
GDI) was differentially regulated in infected birds compared to
uninfected controls. As mentioned above, Ly-GDI represents a group
of proteins i.e. GDI, which are involved in the regulation of another
group of proteins, Rho family GTPases. Apart from its involvement in
the organization of the cytoskeleton, Rho-GTPases are also involved in
cell signalling and proliferation. GDIs are involved in the regulation of
shifting of Rho GTPase between the active GTP-bound form and the
inactive GDP-bound form. Our present observations showed a more
than 5-fold increase of an 18.4 kDa D4-GDI spot while there was a
signiﬁcant decrease of the presumably intact protein of 27 kDa. While
activation as well as apoptosis of different types of cells in response to
viral infections has been well documented, our present observations
may highlight some of the molecules involved in these processes in
the context of MDV infection.
Cathepsin D (CathD), a lysosomal aspartic proteinase, was among
the proteins thatwere differentially expressed in infected spleens at all
three time points. There were two spots with molecular weight of
approximately 13 and 28 kDawhichwere up-regulated, while another
one (39.2 kDa) was down-regulated. CathD is synthesized as a single
chain pre-pro-enzyme and after being cleaved into several successive
intermediates, it forms the mature 34+14 kDa form consisting of a
heavy and a light chain in the lysosome (Laurent-Matha et al., 2006).
Therefore, processing of the 39.2 kDa intermediate into the mature
enzyme appears to be induced by MDV infection. CathD has been
shown to be an important mediator of apoptosis induced through the
lysosomal pathway (Guicciardi et al., 2004).While CathD appears to be
involved in the intrinsic pathway of the induction of apoptosis in
activated T lymphocytes in human (Bidere et al., 2003), itmayalso play
a signiﬁcant role in the resolution of inﬂammation by inducing
apoptosis in neutrophils (Conus et al., 2008). Apart from its role in the
induction of apoptosis, increasing evidence suggests that CathDplays a
signiﬁcant role in cancer progression and metastasis. In the context of
MD, several studies have shown the occurrence of cell death in MDV-
infected organs such as the bursa of Fabricius (St Hill and Sharma,
1999), thymus (Morimura et al., 1996) and in peripheral blood
mononuclear cells (Morimura et al., 1995). While it is conceivable
that up-regulated CathD may play a role in apoptosis during the early
stages ofMD, it mayalso have a role in Tcell transformation in the later
stages of the disease; however, this needs to be further studied.
Transglutaminase 4 (TGM4) is among the proteins with the
highest fold increase in spleens of infected chickens. Generally,
transglutaminases are involved in post-translational modiﬁcation of
proteins (Beninati and Piacentini, 2004). TGM4 is highly expressed in
the prostate gland of humans but little information is available about
the function of this protein in chickens. TGM2, which is a ubiquitously
expressed protein in human (also known as tissue TGM, tTGM), has
been shown to play a signiﬁcant role in stress response (Ientile et al.,
2007) notably in apoptotic cell death. While TGM2 is up-regulated in
apoptotic cells, it acts as a molecular glue and appears to stabilize thedying cells to prevent release of intracellular molecules prior to
clearance by phagocytosis (Fesus and Szondy, 2005) thereby
preventing adverse effects, such as excessive inﬂammatory reactions.
Assuming chicken TGM4 has a similar role as that of human TGM2,
above observations may explain the putative role of the former in the
context of host–MDV interactions in the spleen to prevent collateral
damage to the neighbouring cells.
Enhancement of cellular metabolic process
According to GO classiﬁcation based on the biological process, the
highest association of identiﬁed proteins in the current study was
with metabolic processes (19%) (Fig. 5). Notably, several metabolic
enzymes associated with glycolysis have been found differentially
regulated. Among them, a 38.76 kDa spot representing aldolase B
fructose-bisphosphate (ALDOB) was constantly up-regulated in
infected spleens at all time points. Interestingly, another spot with
similar identity and molecular weight but slightly different pI was
signiﬁcantly down-regulated only at 7 dpi. While different pIs for the
same protein is possible with structural changes such as phosphor-
ylation, functional relevance in this context needs to be elucidated.
Another two newly induced glycolytic enzymes, each at 7 and 21 dpi,
were identiﬁed as triosephosphate isomerase 1 (TPI1) and phospho-
glycerate mutase 1 (PGAM1), respectively. Viruses utilize host cell
metabolic process for their replication process. In agreement with the
present observations, signiﬁcantly elevated levels of several serum
enzymes, including aldolase B, in response to MDV infection in vivo
has been previously described (Ivanov et al., 1974). Further, MDV-
encoded protein pp38 has been shown to up-regulate cellular
metabolic activities in vitro as determined by the enhanced activity
of mitochondrial dehydrogenases (Li et al., 2006). Similarly, human
cytomegalovirus infection in ﬁbroblasts has also shown overall up-
regulation of a number of glycolytic enzymes (Munger et al., 2006).
In conclusion, ﬁndings of the present study highlight some of the
mechanisms involved in the host response in the spleen to MDV
infection during various time points representing different stages of
MDV pathogenesis. Although the functions of the proteins, which
were identiﬁed here, were not studied, it is likely that all or some of
them are involved in host–virus interactions. One of the limitations of
the tools used in this study is the inefﬁciency of detecting low
abundance proteins or those with low molecular weights, such as
cytokines and chemokines. Therefore, a more comprehensive study is
needed to elaborate on our present observations and to further
explore other proteins that may play a role in pathogenesis of the virus
as well as host responses to this virus.
Materials and methods
Experimental animals
All the chickens used in this experiment were one-day old speciﬁc
pathogen free (SPF) chickens obtained from the Animal Disease
Research Institute, Canadian Food Inspection Agency (Ottawa,
Ontario, Canada). Birds were kept in an isolation facility at the
Ontario Veterinary College throughout this experiment.
Infection virus strain
Chickens were infected with the RB1B strain of very virulent
Marek's disease virus (passage 9) (Schat et al., 1982) which was
obtained from Dr. K.A. Schat (Cornell University, NY, USA).
Experimental design
Twenty-four, one-day old chicks were randomly divided into two
groups and were housed in the isolation facility. One group of birds
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of very virulent MDV intraperitoneally on day 5 of age. The rest
(n=12) were kept as uninfected controls. Infected and uninfected
control birds were kept in separate units with similar environmental
conditions. On 7, 14 and 21 dpi, representing different stages of MDV
pathogenesis, four chickens that were randomly selected from each
group were euthanized using CO2 inhalation. At necropsy, a portion of
spleen was collected from each bird and was snap-frozen in liquid
nitrogen. Subsequently, frozen tissues were kept at −80 °C until
further processing. Another portion was preserved in RNAlater
(Qiagen Inc., Missisauga, ON, Canada). Animal experiments were
conducted in accordance with the guidelines provided by the
Canadian Council on Animal Care. All experiments complied with
institutional animal care guidelines and were approved by University
of Guelph Animal Care Committee (protocol number 06R015).
Sample preparation for proteomic analysis
Each frozen spleen tissue was brieﬂy homogenized in a lysis buffer
(pH 8.5) containing 30 mM Tris–Cl, 2 M thiourea, 7 M urea and 4%
(W/V) CHAPS. The volume of lysis buffer used for each tissue sample
was equal to 15 times of tissue mass. Samples were further solubilized
by sonication for 5min on ice and insoluble tissue debris was removed
by centrifugation under 18,000 ×g at 4 °C. Subsequently, supernatant
was collected separately from each sample and protein concentrations
were determined using the Bio-Rad Protein Assay as prescribed by the
manufacturer.
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)
The spleen protein sample from each chicken was analyzed
separately. There were a total of 24 chickens in two groups (infected
and uninfected) i.e. 24 protein samples for analysis by 2D-PAGE. Each
analytical 2D-PAGE gel was prepared with 200 μg of proteins mixed
with rehydration buffer (8 M urea, 2% CHAPS, 90 mM DTT, 5 μl/ml
appropriate IPG buffer, 12 μl/ml Destreak reagent (GE Healthcare) and
0.005% bromophenol blue) to a total volume of 250 μl. The ﬁrst
dimension separation was performed in 13 cm, pH 3–10 non-linear
Immobiline DryStrips (GE Healthcare) using Ettan IPGphor isoelectric
focusing unit (GE Healthcare). After rehydration at 30 V for 12 h,
isoelectric focusing was performed at 500 V for 1 h, 1000 V for 1 h and
8000 V until a total of 57,000 volt hours was reached. Each focused
strip was incubated at room temperature, initially in 10 ml of
equilibration buffer (50 mM Tris–Cl (pH8.8), 6 M urea, 30% (v/v)
glycerol, 2% (w/v) SDS and 0.005% bromophenol blue) containing 1%
(w/v) DTT for 15 min and subsequently in a similar volume of
equilibration buffer containing 2.5% (w/v) iodoacetamide for a similar
time. For the second dimension separation, each IPG strip was placed
on a 12.5% SDS-polyacrylamide gel and four such gels were
simultaneously run each time subjecting them to 25 mA/gel of
current at 25 °C in a Ruby apparatus until the bromophenol blue dye
front reach the opposite edge of the gel. Each gel was subsequently
ﬁxed for 1 h in a solution containing 10% (v/v) methanol and 7% (v/v)
acetic acid, stained with SYPRO Ruby stain (Bio-Rad) overnight and
destained in the ﬁxing solution for 2 h. Gel images were digitized
using Typhoon 9400 variable mode imager (GE Healthcare) at 532 nm
using a 610 nm ﬁlter. Preparative gels were prepared in a similar
manner, using 1 mg of protein from each sample and stained them
with Coomassie brilliant blue instead of SYPRO Ruby.
Quantiﬁcation and comparison of protein expression
Digitized gel images were used to estimate the expression of
different proteins in each analytical gel using 2004 version of Phoretix
2D software (Nonlinear Dynamics). The pixel volume of each detected
spot was referred to as the spot volume and was used in thesubsequent comparisons. Background correction for pixel volumes of
each spot was done using the mode of non-spot and normalized spot
volumes were calculated as a fraction against the total volume of spots
in each gel. The spots which were not present in the expected position
or showed decreased intensity were considered “down-regulated”,
while the spots that appeared in only one group or showed enhanced
intensity were considered “up-regulated”. Although this is an
indicator of protein abundance, the possibility of post-translation
modiﬁcations, hence changes in location of spots on the 2D-PAGE gels,
could not be ruled out in our study.
Statistical analysis
There were eight 2D-PAGE gels per time point: 4 derived from
infected spleens and 4 from those of uninfected birds. Only the spots
that were present in all gels and those that were absent from a
maximum of one analytical gel per group at a given time point were
considered for the statistical comparison. Statistical analysis was
done using SAS (version 9.1). Normalized volumes of each
corresponding spot from each group at similar time point were
compared with Student t-test. The resulting P values were used to
calculate the FDR. Spots that were having both P≤0.01 and fold
difference N2 in mean normalized volumes were considered as
signiﬁcantly differentially expressed. FDR for any selected spot was
less than 5%.
Protein identiﬁcation
The spots that showed a signiﬁcant difference, and those expressed
only in a particular group at a given sampling point, were selected for
identiﬁcation by 1D LC ESI MS/MS using a LCQ Deca XP Plus mass
spectrometer coupled with two Thermo Surveyor MS Pump quatern-
ary gradient pumps at the Life Science and Biotechnology Institute,
Mississippi State University as described below.
Each selected spot was excised manually from Coomassie brilliant
blue stained preparative gels and “in-gel” digested exactly as
previously described (Shevchenko et al., 1996). Proteins were reduced
with 5 mM DTT at 65 °C for 5 min and alkylated with 10 mM
iodoacetamide at 30 °C for 30 min. Trypsin digestion was done using
molecular biology grade porcine trypsin (2 μg; 37 °C; 16 h; 50:1 ratio
of protein:trypsin; Promega Corporation, Madison, WI). Liquid
chromatography was done with a reverse phase (C18) LC column
coupled directly in line with the mass spectrometer. Peptides were
loaded into a liquid chromatography gradient ion exchange system
containing a Thermo Separations P4000 quaternary gradient pump
(ThermoElectron Corporation; San Jose, CA) coupled with a
0.18×100 mm BioBasic C18 reverse phase liquid chromatography
column of a Proteome X workstation (ThermoElectron). The reverse
phase gradient used 0.1% formic acid in acetonitrile and increased the
acetonitrile concentration in a linear gradient from 5% to 30% in
15 min and then 30% to 65% in 5min followed by 95% for 5 min and 5%
for 10 min. The mass spectrometer was conﬁgured to optimize the
duty cycle length with the quality of data acquired by alternating
between a single full MS scan followed by three tandem MS scans on
the three most intense precursor masses (as determined by Xcalibur
software in real time) from the full scan. The collision energy was
normalized to 35%. Dynamic mass exclusion windows were set at
2 min and all of the spectra were measured with an overall mass/
charge (m/z) ratio range of 300–1700. Identiﬁcation of all spots was
done as a single run in a randomized order. To prevent “carry-over”
after the peptides generated from each spot were analyzed, and before
those from the next spot were analyzed, the LC column was washed
with 95% ACN, a negative control sample was run to conﬁrm no carry-
over and the LC column was washed again.
Resulting mass spectra were analyzed using Bioworks 3.2
(ThermoElectron) using a non-redundant proteome database
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downloaded from the NCBI. We used the Bioworks reverse database
function to create the decoy database from this proteome database.
The probability of the tandem mass spectrometry match occurred by
chancewas calculated using; (A) the decoy database searching exactly
as described by Elias and Gygi (2007) and (B) the orthogonal P(pep)
function in Bioworks 3.2 (which calculates probability based on a
theoretical y and b ion spectrum calculated based on theoretical
amino acid dissociation). These two probabilities were the used to
calculate the FDR as described by Benjamini and Hochberg (1995) and
only peptides with FDRb0.01 were considered as a signiﬁcant and
retained for protein identiﬁcation. The probability of protein identity
was then calculated from the peptide probabilities exactly as
described (MacCoss et al., 2002; Nesvizhskii et al., 2003). To calculate
the percent protein coverage by identiﬁed peptides, the protein
sequence was digested in silico using “peptidecutter” (http://us.
expasy.org/tools/peptidecutter/ (Gasteiger et al., 2005)) and the
total number of amino acids in peptides between 6 and 30 amino acids
(the size range of 99% of the peptides detected by the mass
spectrometer) was used as the denominator; the peptides identiﬁed
were used as the nominator. For spots withmultiple protein identities,
the protein with the highest peptide coverage and highest protein
score (i.e. ΣXcorr; a surrogate for the amount of precursor ion)
(Nanduri et al., 2005) was considered as the dominant protein and the
most likely protein to contribute to the differential expression in the
gel. Subsequently, their biological relevance was discussed.
Gene Ontology (GO) analysis
Spot identities were submitted to GORetriever (http://www.
agbase.msstate.edu/) to obtain the GO annotations. If no annotation
was returned, GOanna was used to retrieve GO annotations assigned
depending on the sequence similarities. The resulting annotations
were summarized based on the GOA and whole proteome GOSlim set
using GOSlimViewer (McCarthy et al., 2006).
Determination of MDV genome load in infected spleen tissues
DNA extraction, conventional PCR conﬁrmation of the presence of
MDV-Meq gene and subsequent determination of the absolute MDV
genome copy number from infected spleen samples were essentially
performed as previously described (Abdul-Careem et al., 2006).
Quantitative real-time PCR reactions to determine viral genome load
in samples were performed in duplicate.
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